There are many different approaches to keeping HIV under control in vulnerable communities. There are treatment measures through drugs, additional preventative measures such as safe sex practices and educational programs. High on the list for treatment through prevention are pre-infection HIV drugs.
There are different types of drugs given to patients and at-risk individuals to lessen the risk of transmission. Here are some of the most common and most effective treatment methods for HIV prevention.
The prevention of HIV transmission is one of the core focuses with HIV in America, and across the world. Where possible, communities at risk of HIV encounter the “test and treat” method of healthcare. All individuals receive testing for HIV where necessary.
All those who test positive then get the appropriate drugs to stop them from passing the disease to others. These ART drugs are a vital tool in many HIV/Aids programs and have led to some great results in reducing transmission rates.
The smaller the viral count in the blood, semen, and other fluids, the less likely it is that others will be at risk of infection. These preventative measures are then complemented with education programs, sexual health advice and Post-Exposure Prophylaxis for emergency situations.
ART drugs have had a massive impact in reducing transmission rates in the major African and American populations.
ART treatment is most often administered to HIV-positive patients to stop the spread of the disease. There is always the risk that the illness could transfer through bodily fluid and blood. This occurs through sexual intercourse, blood contact and the sharing of needles.
HIV-positive individuals take these drugs to reduce to CD4 counts to “undetectable” levels. Their use was then rolled out through many projects because of continual positive results.
A 2011 saw transmission levels from HIV-positive individuals to HIV-negative partners reduced by up to 96%. This is vital for those that want to continue a normal relationship without putting a non-infected partner at risk.
ART methods are developing into new areas and treatment methods other than pills. One of the interesting solutions is the use of microbicide creams and gels applied before intercourse.
The formulas work to limit the risk of transmission. However, it is not the most reliable of approaches, especially when it comes to unplanned sex.
Then there are the pre-infection HIV drugs for non-infected partners.
There are often two sides of these relationships. On the one hand, you have an HIV-positive person taking drugs to reduce the risk and deal with the condition.
On the other, you are also likely to find an HIV-negative partner that could put themselves at risk. Responsible work in pre-infection treatment options will look at both sides of the relationship.
It is much easier to lessen the risk of transmission if both partners are working to hinder the disease.
Non-infected patients in relationships with infected partners can take daily drugs to target the illness. The aim here is to flood the bloodstream with drugs that inhibit the progression of HIV, should it pass between partners.
Truvada is the most common of these preventative drugs for non-infected patients. It comprises of Emtricitabine (200 mg) and Tenofovir Disoproxil Fumarate (300 mg) in one simple, daily pill.
The aim here is to increase the number of CD4 cells to reduce the viral load in the bloodstream and other fluids. This may be the more well-known of the pre-infection drugs around, but it is part of a larger cocktail.
As with all HIV drugs, there are significant conditions that affect their potency.
It is easy for couples to look at the actual statistics for transmission reduction and believe that they are completely safe. However, couples cannot get complacent or let down their guard.
There is always a small chance that the drugs will not work. There is no 100% guarantee of success here, just a great reduction in the number of transmissions. Also, users need to remember that they need to take these drugs daily for them to work.
A few missed days or an unfinished course could leave the bloodstream too diluted and vulnerable. Finally, these pre-infection HIV treatment options are no substitute for safe sex practice.
Couples should not give up on the condoms just because they are on these drugs.